These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 26811644)

  • 21. [Inflammatory intestinal diseases: ulcerative colitis and Crohn's disease. Early diagnosis and treatment].
    Belohlavek D; Koch H; Morl M
    Fortschr Med; 1976 Mar; 94(7):358-62. PubMed ID: 9346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease.
    Romberg-Camps MJ; Dagnelie PC; Kester AD; Hesselink-van de Kruijs MA; Cilissen M; Engels LG; Van Deursen C; Hameeteman WH; Wolters FL; Russel MG; Stockbrügger RW
    Am J Gastroenterol; 2009 Feb; 104(2):371-83. PubMed ID: 19174787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic value of serum procalcitonin in determining the activity of inflammatory bowel disease.
    Oruç N; Ozütemiz O; Osmanoğlu N; Ilter T
    Turk J Gastroenterol; 2009 Mar; 20(1):9-12. PubMed ID: 19330729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biomarkers for inflammatory bowel disease.
    Foley KF; Kao P
    Clin Lab Sci; 2007; 20(2):84-8. PubMed ID: 17557707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammatory bowel disease.
    Statter MB; Hirschl RB; Coran AC
    Pediatr Clin North Am; 1993 Dec; 40(6):1213-31. PubMed ID: 8255623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis and management of inflammatory bowel disease in children.
    Carvalho R; Hyams JS
    Semin Pediatr Surg; 2007 Aug; 16(3):164-71. PubMed ID: 17602971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's disease.
    Sipeki N; Davida L; Palyu E; Altorjay I; Harsfalvi J; Szalmas PA; Szabo Z; Veres G; Shums Z; Norman GL; Lakatos PL; Papp M
    World J Gastroenterol; 2015 Jun; 21(22):6952-64. PubMed ID: 26078573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year.
    Guidi L; Marzo M; Andrisani G; Felice C; Pugliese D; Mocci G; Nardone O; De Vitis I; Papa A; Rapaccini G; Forni F; Armuzzi A
    Dig Liver Dis; 2014 Nov; 46(11):974-9. PubMed ID: 25096964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential diagnosis in inflammatory bowel disease colitis: state of the art and future perspectives.
    Tontini GE; Vecchi M; Pastorelli L; Neurath MF; Neumann H
    World J Gastroenterol; 2015 Jan; 21(1):21-46. PubMed ID: 25574078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Normalization of faecal calprotectin: a predictor of mucosal healing in patients with inflammatory bowel disease.
    Røseth AG; Aadland E; Grzyb K
    Scand J Gastroenterol; 2004 Oct; 39(10):1017-20. PubMed ID: 15513345
    [No Abstract]   [Full Text] [Related]  

  • 31. [Application of chosen granulocyte markers in diagnostics of Leśniowski-Crohn's disease and ulcerative colitis--preliminary research].
    Fedak D; Pawlica D; Ciećko-Michalska I; Solnica B; Mach T
    Przegl Lek; 2010; 67(2):114-8. PubMed ID: 20557011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An investigation into the validity of the present classification of inflammatory bowel disease.
    Holdstock G; Savage D; Harman M; Wright R
    Q J Med; 1985 Feb; 54(214):183-90. PubMed ID: 3983358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Ulcerative colitis and Crohn's regional enterocolitis. Common aspects and differentiation].
    Fahrländer H
    Med Klin; 1975 Oct; 70(40):1583-94. PubMed ID: 1102889
    [No Abstract]   [Full Text] [Related]  

  • 34. [Surveillance of patients with chronic inflammatory intestinal diseases: problems relevant to clinical practice].
    Hoffmann R
    Praxis (Bern 1994); 1994 Oct; 83(42):1186-9. PubMed ID: 7973267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of three commercial fecal calprotectin ELISA test kits used in patients with Inflammatory Bowel Disease.
    Mirsepasi-Lauridsen HC; Bachmann Holmetoft U; Ingdam Halkjær S; Angeliki Krogfelt K; Munk Petersen A
    Scand J Gastroenterol; 2016; 51(2):211-7. PubMed ID: 26359672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Update on the etiology, pathogenesis and diagnosis of ulcerative colitis.
    Hanauer SB
    Nat Clin Pract Gastroenterol Hepatol; 2004 Nov; 1(1):26-31. PubMed ID: 16265041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammatory bowel disease: implications for the medical-surgical nurse.
    Cox J
    Medsurg Nurs; 1995 Dec; 4(6):427-34; quiz 435-7. PubMed ID: 8696390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Inflammatory bowel diseases (IBD) -- critical discussion of etiology, pathogenesis, diagnostics, and therapy].
    Ochsenkühn T; Sackmann M; Göke B
    Radiologe; 2003 Jan; 43(1):1-8. PubMed ID: 12552369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The characteristics of the clinical picture and treatment of nonspecific ulcerative colitis and Crohn's disease].
    Ryss ES; Fishzon-Ryss IuI
    Ter Arkh; 1990; 62(2):150-3. PubMed ID: 2186495
    [No Abstract]   [Full Text] [Related]  

  • 40. Who and how to screen for cancer in at-risk inflammatory bowel disease patients.
    Parian A; Lazarev M
    Expert Rev Gastroenterol Hepatol; 2015 Jun; 9(6):731-46. PubMed ID: 25592672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.